MetLife Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.05M Sell
10,062
-391
-4% -$118K 0.02% 790
2025
Q1
$3.46M Sell
10,453
-365
-3% -$121K 0.02% 796
2024
Q4
$3.34M Buy
10,818
+695
+7% +$214K 0.02% 782
2024
Q3
$2.15M Hold
10,123
0.01% 982
2024
Q2
$2.84M Buy
10,123
+2,537
+33% +$711K 0.02% 811
2024
Q1
$2.03M Sell
7,586
-172
-2% -$45.9K 0.01% 942
2023
Q4
$1.8M Buy
7,758
+581
+8% +$134K 0.01% 988
2023
Q3
$1.05M Hold
7,177
0.01% 1204
2023
Q2
$1.66M Buy
7,177
+495
+7% +$114K 0.01% 1007
2023
Q1
$1.62M Hold
6,682
0.01% 991
2022
Q4
$1.94M Hold
6,682
0.01% 920
2022
Q3
$434K Hold
6,682
﹤0.01% 1743
2022
Q2
$478K Hold
6,682
﹤0.01% 1700
2022
Q1
$656K Buy
6,682
+2,468
+59% +$242K ﹤0.01% 1610
2021
Q4
$357K Buy
4,214
+527
+14% +$44.7K ﹤0.01% 1693
2021
Q3
$294K Hold
3,687
﹤0.01% 1831
2021
Q2
$359K Hold
3,687
﹤0.01% 1776
2021
Q1
$431K Hold
3,687
﹤0.01% 1616
2020
Q4
$410K Hold
3,687
﹤0.01% 1586
2020
Q3
$438K Hold
3,687
﹤0.01% 1434
2020
Q2
$418K Hold
3,687
﹤0.01% 1484
2020
Q1
$246K Hold
3,687
﹤0.01% 1580
2019
Q4
$336K Hold
3,687
﹤0.01% 1672
2019
Q3
$318K Hold
3,687
﹤0.01% 1676
2019
Q2
$386K Buy
3,687
+564
+18% +$59.1K ﹤0.01% 1630
2019
Q1
$391K Hold
3,123
﹤0.01% 1600
2018
Q4
$352K Hold
3,123
﹤0.01% 1582
2018
Q3
$669K Buy
3,123
+422
+16% +$90.4K 0.01% 1349
2018
Q2
$755K Buy
2,701
+586
+28% +$164K 0.01% 1164
2018
Q1
$247K Hold
2,115
﹤0.01% 1774
2017
Q4
$194K Buy
+2,115
New +$194K ﹤0.01% 1943